Buradasınız

SİGARA KULLANIMI İLE İMPLANT BAŞARISIZLIĞI ARASINDA BAĞLANTI VAR MIDIR?

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Smoking has been shown to be a primary etiologic factor in many serious and potentially fatal diseases. It has been determinated that smoking clinically and macroscopicalSy comprimases soft and hard tissues, human immun system and their cells (neutrophil, phagositor cell, etc.), mediators (IL-1, IL-6, TNF-«, TNF-J3). There is a widespread of usage implants in the field of modem dentistry.Smoking has a negative affect on the success rate of dental implants and some studies suggested that the protocol of smoking cessation effect osseintegration positively. Additional data about patients under implant therapy with smoking habits has been reviewed. It has been suggested that smoking habits and cessation protocols must be considered for succesful osseointegration.
Abstract (Original Language): 
Çağımızın önemli hastalık oluşturan etkenlerinden biri, sigara kullanımıdır. Yapılan çalışmalarda sigaranın olumsuz etkileri ve çok sayıda ölümcül hastalığın oluşmasında başlıca etyolojik faktör olduğu gösterilmiştir. Sigara kullanımının ağız dokularını oluşturan yumuşak ve sert dokular üzerine çeşitli olumsuz etkileri belirlenmiştir. Konağın klinik cevabına etkileri (yara iyileşmesi, plak birikimi, cep derinliği), mikroskopik olarak konak cevabında rol oynayan hücre (nötrofiî, fibroblast, trombosüt, lökosit) gruplarına ve bunların salgıladıkları mediatörlere (IL-1, IL-2, IL-4) karşı negatif etkileri, yapılan çalışmalarda ortaya konmuştur. Bu derlemede yapılan çalışmaların ışığı altında modern diş hekimliğinde yaygın olarak kullanılan implant uygulamalarında sigaranın olumsuz etkileri belirtilmiştir. Literatürde implant uygulamalarında sigara kullanan hasılalarda daha düşük başarı oranlan bildirilmektedir. Implant tedavisinde sigara bırakma protokolünün implant osseointegrasyonunu olumlu yönde etkilediği literatürde bu konuda yapılmış çalışmalarla gösterilmiştir. Ayrıca sigara kullanan hastalarda implant uygulamaları yapılırken, dikkate alınması gereken kriterler (kullanım miktarı ve süresi, nikotin miktarı) konusunda ve önerilen tedavi protokolleri hakkında literatürdeki çalışmalar desteğinde sonuçlar bildirilmiştir.
43
49

REFERENCES

References: 

1. Johson GK,Slach NA.Impact of tobacco use on periodontal status. J Dent Educ 2001; 65: 313-18.
2. Papapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996; 1:1¬5.
3. Papapanou PN.Risk assessments in. the diagnosis and treatment of periodontal diseases. J Dent Educ 1998; 62: 822-24.
4. Hastreiter RJ, Bakdash B, Roesch MH,Walseth U. Position paper: Tobacco use and periodontal patient. J Periodontal 1999; 70: 1419-23.
5. Tonetti MS. Cigarette smoking and periodontal diseases etiology and managment of disease. Ann Periodontal 1998; 3: 88-91.
6. Golec TS, Krauser JT. Long-term retrospective studies on hydroxyapaptitr-coated endosteal and subperiosteal implants. Dent Clin North Am 1992; 36: 39-47.
7. Johson B: HA-coated dental implants: long term consequences. Calif Dent Assoc J 1992; 20: 33-6.
8. Jovasonic S A, Kenny EB, Caranza FA. The regenerative potential of plaque-induced perimplant bone defects treated by a submerged membrane technique. An experimental study. Int J Oral Maxillofacial Impl 1993; 8:13-21.
9. Benjamin SD, Baer PN. Familial patterns of advanced alveolar bone loss in adolescence (periodontisis). Periodontics 1967; 5: 82-7
10. Boughman JA, Beaty TLLYang P. Problems of genetic model testing in early onset periodontitis. J Periodontol 1988; 59: 332-41.
11. Cantor RM, Rotter JI. Analysis of genetic data. Methods and interpreatation.In:King RA, Rotter JI, Motuisky AG (eds): The genetic Basis of Common Diseases. Oxford University Pres, New York, 1992: 266-78.
12. Scully CE, MacFayden A, Campbell A. Oral manifestations in cyclic neutropenia. Br J Oral Surg 1982; 20: 96-8.
F.4
13. Kastlİn G. Agranulocytic angina. Am J MedSci 1927; 173: 799-803.
14. Kracke RR.Granulopenia as associated with amidopyrine administration. Report made at the Annual Session of the Ama 1934.
15. Mark HA. Agranulocytic angina.Its oral manifestations. J Am Dent Assoc 1934; 21: 119-24.
16. Ah MKB, Johson GK, Kaihdal WB. The effect of smoking on the response to periodontal therapy.J Clin Periodontol 1984; 21; 91-5.
17. Albandar JM, Streckfus CF, Adesanya MR. Cigar, pipe and tooth loss, J Periodontol 2000; 71: 1874-77.
18. Bergstrom J, Preber H. The influence of cigarette smoking on the devolopment of experimental gingivitis. J Periodont Res 1986;21:668-73.
19. Bergstrom J, Eliasson S, Dock J. A 10-years prospective study of tobacco smoking and periodontal health. J Peridontol 2000; 71: 1338-45.
20. Johnson GK, Slach NA. Impact of Tobacco use on periodontol status. J Dent Educ 2001; 65: 313-16.
21. Schenkein HA, Gunsoley JC, Koertge TE. Smoking and its effects on early-onset periodontitis. J Am Dent Assoc 1995; 126: 1107-09.
22. Tonetti MS. Cigarette smoking and periodontal diseases: Etiology and managment of diseases. Ann Periodontol 1998; 3: 88-94.
23. Kenney EB, Kraal JH, Saxe SR. The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodont Res 1977; 12: 227-31.
24. MacFarlane GD, Herzberg MC, Wolf LF. Refractory periodontitis associated with abnormal polymorphonuclear leukocyte phagocytosis and cigarette smoking. J Periodontol 1992; 63: 908-10.
25. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999; 70: 13-21.
48
Cüneyt KARABUDA, Erkan AKILLI, Selim ERSANLI
26. Folkers SA, Weine PS, Wissman DP. Periodontal disease in the life stage of women. Compendium 1992; 13: 852-56.
27. Preber H, Bergstrom J, Linder LE. Occurence of periopathogens in smoker and nonsmoker patients. J Clin Periodontol 1992; 19: 667-73.
28. Stoltenberg JL, Osborn JB, Pihistrom BL. Association between cigarette smoking, bacterial pathogens and periodontal status. J Periodontol 1993; 64:1225-36.
29. Zambon JJ, Grossi SG, Machtei E. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996; 67: 1050¬54.
30. Dinsdale CR, Rawlinso A, Walsh TF. Subgingival temperature in smokers and nonsmokers with periodontal disease. J Clin Periodontol 1997; 24:761-68.
31. Person L, Bergstrom J. Smoking and vascular density of healthy marginal gingiva. Eur J Oral Sci 1998; 106: 953-56.
32. Kenney EB, Kraal JH, Saxe SR. The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodont' Res 1977; 12: 227-32.
33. Ryder MI, Johnson G. Alteration of neutrophil oxidative burst by in vitro smoke Exposure: Implications for oral and systemic diseases. Ann periodontol 1998; 3: 76-81.
34. Barbour S, Nakashim K. Tobacco and smoking enviromental factors that modify the host response (immune system) and have an impact on peridontal health. Crit Rev Oral Bio Med 1997; 8: 437-441.
35. Costabel U, Bross K, Reuter C. Alterations in immunoregul atory T-cel 1 s ub sets in cigarette smokers. A phenotypic analysis of broncohoalveolar and blood lymhocytes. J Periodontol 1998; 69: 171¬176.
36. Quinn S, Zhang J. Gunsolley J. The influence of smoking and race on adult periodontitis and serum IgG2 levels.J Periodontol 1998; 69: 171-83.
37. Ataoğlu H, Alptekin NO. Interleukin-1 beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crecivicular fluid. Clin Oral Implants Res 2002; 7.13-19.
38. Codd EF, Swim AT, Bridges RB. Tobacco smokers neutrophils are desentized to chemotactic peptide-stimulated oxygen uptake. J Lab Clin Med 1987; 110:648-58.
39. Lannan S, McLean A, Drost E. Changes in neutrophil morphology and morphmetry" following exposure to cigarette smoke. Int J Exp Pathol 1992; 73: 183-95.
40. Selby C. Drost E, Brown D. Inhibition of neutrophil adherence and movement by acute cigarette smoke Exposure. Exp Lung Res 1992; 18: 813-21.
41. Bostrum L, Linder LE, Bergstrom J. Clinical expression of TNF-°= in smoking-associated periodontal disease. J Clin Periodontol 1998; 70: 730-39.
42. Rota MT, Poggi P, Baratta L, Gaete E, Boratta R, Tazzi A. Tobacco smoking İn the devolopment and therapy of periodontal disease. Progress an question. Bull Group Int Reach Sci Stomatol Odontol. 1999 October; 41(4): 116: 2-15.
43. Scabbia A, Cho K, S, Sigurdsson TJ. Cigarette smoking negativly affects healing response following flab debridement surgery. J Periodontol 2001; 72: 43-61.
44. Rosen PS, Marks MH, Reynolds MA. Influence of smoking on long term clinical reults of intrabony defects treated with regenerative therapy. J periodontol 1996; 67: 1159-67.
45. Sham A., Cheung L., Jin LJ., Corbet EF. The effects of tobacco use on oral health. Hong Kong Med J 2003; 9: 271-227-242.
46. Bergstrom J, Elİasson S, Dock J. Exposure to tobacco smoking and periodontol health. Clinic Periodontal 2000; 6; 211-25.
47. Bokor-Bratic M. Effects of smoking on the periodontium. Medcinski Fakultet, Klinka za stomatologyu, 21000 Novİ Sda, Hajduk Veljkova. Med Pregi 2002; 18: 441-552.
Sigara Kullanımı ile Implant Başarısızlığı Arasında Bağlantı Var
49
48. Johson GK, Slach NA. Impact of tobacco use on periodontal status. J Educ. 2001; 51; 663: 775.
49. Kerdvongbundit V, Wikesjo UM. Effect of smoking on periodontol health in molar teeth. J Periodontol 2000; 71 (3): 433-439.
50. Bain CA, Moy PK. The influence of smoking on bone quality and implant failure. Int Oral Maxillofacial Implants 1994; 9: 123-34.
51. Karousis L, Salvi G., Mayfield L., Bragger U., Hammerle C., Lang N. Long term implant prognosis in patients with and without a history of chronic periodontitis: a 10 yearprospeedve cohort study of the ITI dental implant system.Clin Oral Impl Res 2003: 14; 329-39.
52. Bain CA, Moy PK. The assocation beween the failure of dental implants and cigarette smoking. Int Oral Maxillofac Implants 1993; 8: 609-15.
53. De Bruyn H, Colaert B. The effect of smoking on early implant failure. Clin Oral Implants Res 1994; 5: 260-274.
54. Crawford A, Bain. Smoking and implant failure-benefits of a 'smoking cessation protocol. Int Oral Maxillofacial Implants 1996; 11:756-759-773.
55. Haber J, Wattles J, Crowley M. Evidence for cigarette smoking as a major risk factor periodontitis. J Periodontol 1993; 64; 16¬28.
56. Trombelli M, Kim CK, Zimmerman GJ. Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in infrabony defects. J Clin Periodontol 1997; 24: 366¬79.
57. Krall EA, Garvey AJ, Garcia RI. Alveolar bone loss and tooth loss in male Cigar and pipe smokers. J Am Dent Assoc 1999; 130: 57-70.
58. Bergstrom J, Preber H. The influence of cigarette smoking on the development of experimental gingivitis. J Periodont Res 1986;21:668-80.
59. Ketabi M, Hirsch RS. The effects of local anasthetic containing adrenaline on gingival blood flow in smokers and nonsmokers. J Clin Periodontol 1997; 24: 888-901.
60. Trikilis N, Rawlinson A, Walsh TF. Periodontal probing depth and subgingival temperature in smokers and nonsmokers. J Clin Periodontol 1999; 26: 38-53.
61. Bolin A, Eklund G, Frithiof L. The effect of changed smoking habbits on marginal alveolar bone loss: a longitudinal study. SwedDent J 1993; 17: 211-24.
62. Preber H, Bergstrom J. Cigarette smoking in patient referred for periodontal treatment. Scand J Dent Res. 1986 April; 94(2): 102¬8.

Thank you for copying data from http://www.arastirmax.com